Krea eKnowledge Private Limited, India-based Healthcare Decision Support Specialist appoints Sridhar Mani as the Chief Revenue Officer. Sridhar will be based in the Chennai Headquarters. Sridhar will be instrumental in expansion of the core R&D wing to cater to the increasing global demand for Indian Insights. He will also focus on agile research and introduction of innovative service streams.
Krea has one of India’s largest Healthcare decision panels and validated healthcare ecosystem databases.
Prior to this role, Sridhar was associated with Worthy Shout Market Research Services as one of the founders.
Sridhar has fifteen years of experience in the Market Research Industry with primary focus on the Data Collection space for Market Research. Having spent years into various large scale Market Research Projects, Sridhar has a sharp acumen for solving complex research requirements. Sridhar was also a part of Krea during the startup phase heading Operations and new initiatives.
Krea’s Chairman Pravin Shekar says “Sridhar’s addition will give further impetus to Krea’s R&D, strengthen our bonds with medical practitioners, and accumulate deeper insights from the Indian healthcare ecosystem.”
“I am delighted to be back in Krea, where it all began for me as a Research Professional.” said Sridhar Mani. “I believe that this will be a remarkable journey in my career where I shall work more closely with existing and emerging clients across the globe. '', he further added.
Release ID: 397113
This content is published on behalf of the above source. Please contact them directly for any concern related to the above.
This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.